You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 24, 2024

CLINICAL TRIALS PROFILE FOR GABOXADOL


✉ Email this page to a colleague

« Back to Dashboard


Clinical Trials for Gaboxadol

Trial ID Title Status Sponsor Phase Summary
NCT00094627 ↗ Adult Primary Insomnia Polysomnographic Study (0928-004)(COMPLETED) Completed H. Lundbeck A/S Phase 3 The purpose of the study is to test the safety and effectiveness of the Investigational Drug on insomnia.
NCT00094666 ↗ Elderly Primary Insomnia Polysomnographic Study (0928-002)(TERMINATED) Terminated H. Lundbeck A/S Phase 3 The purpose of the study is to test the safety and effectiveness of an Investigational Drug on insomnia in the elderly.
NCT00095043 ↗ Safety of MK0928 on Insomnia in the Elderly (0928-005)(COMPLETED) Completed H. Lundbeck A/S Phase 3 The purpose of this trial is to study the safety of MK0928 on insomnia in the elderly.
NCT00095069 ↗ Efficacy and Safety of MK0928 for Insomnia in Adults (0928-003)(COMPLETED) Completed H. Lundbeck A/S Phase 3 The purpose of this trial is to study the safety and effectiveness of MK0928 for adults with insomnia.
>Trial ID >Title >Status >Phase >Summary

Clinical Trial Conditions for Gaboxadol

Condition Name

Condition Name for
Intervention Trials
Primary Insomnia 9
Insomnia 5
Angelman Syndrome 3
Fragile X Syndrome 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for
Intervention Trials
Sleep Initiation and Maintenance Disorders 14
Syndrome 5
Angelman Syndrome 4
Fragile X Syndrome 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Gaboxadol

Trials by Country

Trials by Country for
Location Trials
United States 36
Israel 3
Germany 2
Australia 2
Sweden 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for
Location Trials
Tennessee 5
Illinois 5
Pennsylvania 4
Ohio 4
California 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Gaboxadol

Clinical Trial Phase

Clinical Trial Phase for
Clinical Trial Phase Trials
Phase 3 13
Phase 2 6
Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for
Clinical Trial Phase Trials
Completed 16
Terminated 2
Unknown status 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Gaboxadol

Sponsor Name

Sponsor Name for
Sponsor Trials
H. Lundbeck A/S 15
Ovid Therapeutics Inc. 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for
Sponsor Trials
Industry 20
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.